Differential crizotinib response duration among ALK fusion variants in ALK-positive non–small-cell lung cancer

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FCBC55EC.svg?ark=w1%2F20260515%2FFCBC55EC)](https://nobleid.org/work/w1/20260515/FCBC55EC)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors